This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Treatment of Late Abortion: Evacuatio Uteri or Conservative Treatment

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified November 2005 by Rigshospitalet, Denmark.
Recruitment status was:  Not yet recruiting
Information provided by:
Rigshospitalet, Denmark Identifier:
First received: November 18, 2005
Last updated: May 31, 2006
Last verified: November 2005
A randomize trial: expectation or evacuatio uteri for the treatment after late abortion

Condition Intervention Phase
Abortion, Spontaneous Abortion, Induced Drug: Cytotec Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Evacuatio Uteri or Conservtive Treatment After Late Abortion. A Randomize Trial.

Resource links provided by NLM:

Further study details as provided by Rigshospitalet, Denmark:

Primary Outcome Measures:
  • Side-effect
  • Complication

Secondary Outcome Measures:
  • Quality of life

Estimated Enrollment: 200
Estimated Study Completion Date: January 2009
Detailed Description:
A randomize trial adressing 200 women consecutively recruited from clinical practice at Rigshospitalet.Expectation: administration of 800 microgram Cytotec half an hour after delivery. Surgery: Evacuation of the uterus

Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

abortion at gestational age (ultrasound) 14+0 - 20+0

Exclusion Criteria:

Allergy to cytotec

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00256009

Contact: Lars Alling Møller, Md phd 0045 35451338

Sponsors and Collaborators
Rigshospitalet, Denmark
Principal Investigator: Lars Alling Møller, MD phd Rigshospitalet, Denmark
  More Information Identifier: NCT00256009     History of Changes
Other Study ID Numbers: KF 01 279545
Study First Received: November 18, 2005
Last Updated: May 31, 2006

Keywords provided by Rigshospitalet, Denmark:
Late abortion

Additional relevant MeSH terms:
Abortion, Spontaneous
Pregnancy Complications
Abortifacient Agents, Nonsteroidal
Abortifacient Agents
Reproductive Control Agents
Physiological Effects of Drugs
Anti-Ulcer Agents
Gastrointestinal Agents
Oxytocics processed this record on September 21, 2017